Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MIA3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | PAQR4 | FIMM | pan-cancer | AAC | -0.55 | 0.009 |
mRNA | FBXL7 | CCLE | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | PGM3 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | DNAJB14 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
mRNA | ELOVL2 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | PARG | FIMM | pan-cancer | AAC | 0.53 | 0.009 |
mRNA | NSL1 | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
mRNA | CSGALNACT2 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
mRNA | ATP6V0D2 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |